Assessing cognitive decline for effective screening: evaluating the efficacy of mini-mental status examination and Addenbrooke’s cognitive examination in identifying minimal hepatic encephalopathy in patients with compensated liver cirrhosis
DOI:
https://doi.org/10.18203/2349-3933.ijam20250370Keywords:
Minimal hepatic encephalopathy, Mini-mental status examination, Addenbrooke’s cognitive examinationAbstract
Background: Liver cirrhosis is a progressive disease marked by significant liver scarring and functional impairment. Minimal hepatic encephalopathy (MHE), a common complication, has a global prevalence of 30-84%, and in India, up to 59.7% among cirrhosis patients. Despite its prevalence, routine MHE screenings are infrequent, highlighting a significant gap in cirrhosis management. This study aims to evaluate the efficacy of the mini-mental status examination (MMSE) and the Addenbrooke’s cognitive examination (ACE) in early detection of cognitive impairments in liver cirrhosis patients.
Methods: The study assessed cognitive function in 126 participants (63 males with compensated liver cirrhosis and 63 healthy male controls) using MMSE and ACE. Logistic regression analysis was employed to explore the relationship between cognitive impairment and MHE.
Results: MMSE scores were significantly lower in the cirrhosis group (M=23.73, SD=1.74) compared to controls (M=25.61, SD=1.07), indicating cognitive impairments, especially in orientation and language domains. ACE scores also showed a significant decline in the cirrhosis group (M=80.92, SD=2.66) compared to controls (M=84.98, SD=3.06), particularly in visuospatial abilities.
Conclusions: MHE significantly affects cognitive function in compensated liver cirrhosis patients. Both MMSE and ACE are effective in detecting cognitive impairments, with ACE showing greater sensitivity. Routine cognitive screening using ACE could improve early detection and intervention, enhancing cognitive function and quality of life for cirrhosis patients.
Metrics
References
Premkumar M, Anand AC, Kumar R, Singh S, Gupta A, Choudhary N, et al. Overview of Complications in Cirrhosis. J Clin Exp Hepatol. 2022;12(4):1150-74 DOI: https://doi.org/10.1016/j.jceh.2022.04.021
Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138(7):2332-40. DOI: https://doi.org/10.1053/j.gastro.2010.02.015
Everett PS, Mitchell E, Harris C, Smith A, Jones B, Parsons OA, et al. The relationship between cognitive function and liver function in alcoholism. Br J Psychiatry. 1984;144:521-4. DOI: https://doi.org/10.1192/bjp.144.5.521
Tarter RE, Sandford SL, Hays AL, Bonner MJ, Perry G, Serper MR, et al. Hepatic injury correlates with neuropsychologic impairment. Int J Neurosci. 1989;44(1-2):75-82. DOI: https://doi.org/10.3109/00207458908986185
Kalra A, Yetiskul E, Wehrle CJ, Tuma F. Physiology, Liver. StatPearls. Treasure Island (FL): Stat Pearls Publishing Copyright. Stat Pearls Publishing LLC. 2024.
Nordlie RC, Foster JD, Lange AJ, Krebs HA, Levitz ML, Iynedjian PB, et al. Regulation of glucose production by the liver. Annu Rev Nutr. 1999;19:379-406. DOI: https://doi.org/10.1146/annurev.nutr.19.1.379
Trefts E, Gannon M, Wasserman DH, Krebs HA, Levitz ML, Miller RA, et al. The liver. Curr Biol. 2017;27(21):R1147-51. DOI: https://doi.org/10.1016/j.cub.2017.09.019
Ochoa-Sanchez R, Rose CF, Bémeur D, Butterworth RF. Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease. J Clin Exp Hepatol. 2018;8(3):262-71. DOI: https://doi.org/10.1016/j.jceh.2018.08.001
Butterworth RF, Morgan MY, Amodio P, Blei AT, Fisher B, Jalan R, et al. Hepatic encephalopathy. Alcohol Res Health. 2003;27(3):240-6.
Sharma A, Nagalli S, Kumar R, Singh S, Gupta A, Choudhary N, et al. Chronic Liver Disease. StatPearls. Treasure Island (FL). 2024.
Shawcross DL, Davies NA, Williams R, Jalan R, Mookerjee R, Laurie S, et al. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40(2):247-54. DOI: https://doi.org/10.1016/j.jhep.2003.10.016
Rathi S, Chopra M, Chouduri G, Agarwal A, Sharma P, Singh S, et al. Prevalence of Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis: A Cross-Sectional, Clinicoepidemiological, Multicenter, Nationwide Study in India: The PREDICT Study. J Clin Exp Hepatol. 2019;9(4):476-83. DOI: https://doi.org/10.1016/j.jceh.2018.09.009
Ortiz M, Jacas C, Córdoba J, Blei AT, Ferenci P, Gines P, et al. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005;42(1):S45-53. DOI: https://doi.org/10.1016/j.jhep.2004.11.028
Huang DQ, Terrault NA, Tacke F, Gluud LL, Arrese M, Bugianesi E, et al. Global epidemiology of cirrhosis- aetiology, trends and predictions. Nature Rev Gastroenterol Hepatol. 2023;20(6):388-98. DOI: https://doi.org/10.1038/s41575-023-00759-2
Butterworth RF, Morgan MY, Amodio P, Blei AT, Fisher B, Jalan R, et al. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol. 2000;32(1):171-80 DOI: https://doi.org/10.1016/S0168-8278(00)80424-9
Zieve L, Montgomery EW, McClain CJ, Becker LB, Diehl AM, Connor JR, et al. Pathogenesis of hepatic encephalopathy. Metabolic Brain Dis. 1987;2(3):147-65. DOI: https://doi.org/10.1007/BF00999607
Corrias M, Turco M, Rui MD, Gatta A, Angeli P, Merkel C, et al. Covert hepatic encephalopathy: does the mini-mental state examination help? J Clin Exp Hepatol. 2014;4(2):89-93. DOI: https://doi.org/10.1016/j.jceh.2013.12.005
Weissenborn K, Bajaj JS, Heuman DM, Wade JB, Bunchorntavakul C, Ferenci P, et al. Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs. 2019;79(1):5-9. DOI: https://doi.org/10.1007/s40265-018-1018-z
Amodio P, Montagnese S, Ambrosio S, Nardone G, Gatta A, Ridola L, et al. Hepatic encephalopathy: Diagnosis and management. Liver Int. 2018;38(6):966-75. DOI: https://doi.org/10.1111/liv.13752
Larner AJ, Mitchell AJ, Mioshi E, Dawson K, Arnold R, Hodges JR, et al. A meta-analysis of the accuracy of the Addenbrooke's Cognitive Examination (ACE) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) in the detection of dementia. Int Psychogeriatr. 2013;26(4):555-63. DOI: https://doi.org/10.1017/S1041610213002329
Koziarska D, Wunsch E, Milkiewicz M, Wójcicki M, Nowacki P, Milkiewicz P, et al. Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study. BMC Gastroenterol. 2013;13:107. DOI: https://doi.org/10.1186/1471-230X-13-107
Kalaitzakis E, Björnsson E, Bunchorntavakul C, Ferenci P, Loomba R, et al. Renal function and cognitive impairment in patients with liver cirrhosis. Scand J Gastroenterol. 2007;42(10):1238-44. DOI: https://doi.org/10.1080/00365520701373983
Berry K, Duarte-Rojo A, Grab JD, Dunn MA, Boyarsky BJ, Verna EC, et al. Cognitive Impairment and Physical Frailty in Patients With Cirrhosis. Hepatol Commun. 2022;6(1):237-46. DOI: https://doi.org/10.1002/hep4.1796
Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, et al. Acetyl-l-Carnitine Treatment in Minimal Hepatic Encephalopathy. Digestive Dis Sci. 2008;53(12):3018-25. DOI: https://doi.org/10.1007/s10620-008-0238-6
Pantiga C, Rodrigo LR, Cuesta M, Gómez-Sánchez E, Gómez-Arnau J, Gómez-Gallego F, et al. Cognitive deficits in patients with hepatic cirrhosis and in liver transplant recipients. J Neuropsychiatr Clin Neurosci. 2003;15(1):84-9 DOI: https://doi.org/10.1176/appi.neuropsych.15.1.84
Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA, et al. Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology. 2011;140(2):478-87. DOI: https://doi.org/10.1053/j.gastro.2010.08.061
Sidhu SS, Goyal O, Parker RA, Kishore H, Sood A. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy. Liver Int. 2016;36(3):378-85. DOI: https://doi.org/10.1111/liv.12921
Downloads
Published
How to Cite
Issue
Section
